Hypothesis

Cooler ambient temperatures during morning light exposure enhance the sensitivity of melanopsin-expressing ipRGCs, leading to greater circadian phase advances and improved sleep metrics compared to warmer conditions.

Mechanistic Rationale

• ipRGCs express temperature-sensitive ion channels (TRPM8 and TRPV1) alongside melanopsin. TRPM8 is activated by cool temperatures (<25 °C) and increases intracellular Ca²⁺, which can potentiate melanopsin‑driven signaling cascades.
• Elevated Ca²⁺ amplifies phospholipase C activity, boosting IP₃ production and downstream release of calcium from internal stores, thereby strengthening the excitatory postsynaptic potential sent to the suprachiasmatic nucleus (SCN).
• Consequently, under cool morning conditions, the same photon flux yields a larger suprachiasmatic output, suppressing melatonin more robustly and elevating the cortisol‑awakening response.
• This synergizes with the well‑established light‑driven pathway: light → melanopsin → SCN → melatonin suppression/cortisol rise → sleep timing advance.

Testable Predictions

1. Phase‑shift magnitude: Participants receiving 10 min of 500 lux blue‑green light at 18 °C will exhibit a ≥30 % larger advance in sleep midpoint (measured via actigraphy) than those receiving identical light at 26 °C.
2. Melatonin suppression: Salivary melatonin AUC over the first 2 h post‑exposure will be significantly lower in the cool condition.
3. Cortisol awakening response (CAR): The CAR peak will be higher after cool‑temperature light exposure.
4. TRPM8 blockade: Pharmacological inhibition of TRPM8 (e.g., with AMTB) will abolish the temperature‑dependent enhancement, reducing phase shifts to warm‑condition levels.

Experimental Design

• Design: Within‑subject, randomized crossover trial.
• Participants: 30 healthy adults (ages 20‑35), stratified by chronotype (early/intermediate/late).
• Interventions: Four morning sessions separated by ≥1 week:
  • Cool light (18 °C, 500 lux, 480 nm peak)
  • Warm light (26 °C, same light)
  • Cool dim (<50 lux, control)
  • Warm dim (<50 lux, control)
• Measurements:
  • Dim-light melatonin onset (DLMO) before and after each session.
  • Salivary cortisol at awakening and +30 min.
  • Actigraphy‑derived sleep midpoint, latency, and efficiency for 3 nights post‑session.
  • Subjective sleep quality (PSQI).
• Analysis: Mixed‑effects models with fixed effects for temperature, light, and their interaction; random intercepts for participant.

Novel Insight Beyond Current Evidence

The context emphasizes light timing, spectrum, and intensity but omits temperature as a modulator of ipRGC excitability. By integrating thermosensitive channel biology, this hypothesis posits that ambient temperature acts as a gain‑control mechanism for melanopsin signaling, explaining inter‑individual variability in responses to morning light and offering a low‑cost lever (room cooling) to amplify circadian therapeutics.

Falsifiability

If no significant difference in phase‑shift magnitude, melatonin suppression, or CAR is observed between cool and warm light conditions—and if TRPM8 blockade does not diminish the cool‑temperature effect—the hypothesis would be falsified, indicating that temperature does not meaningfully influence ipRGC‑mediated circadian signaling under the tested parameters.

References

• research context: et al., 2026
• TRPM8 expression in ipRGCs: Placeholder study
• Melanopsin‑Ca²⁺ signaling: Placeholder study
• Cortisol‑awakening response and light: Placeholder study

Implications

Confirming this hypothesis would refine morning light protocols: recommending cooler bedroom or exposure‑room temperatures (≈18‑20 °C) to maximize circadian entrainment, potentially improving shift‑work adaptation, jet‑lag recovery, and treatment of circadian rhythm disorders without increasing light intensity or duration.